London, UK; Brentwood, TN, US: 24 June 2008 - Protherics PLC
("Protherics" or the "Company"), the international biopharmaceutical
company focused on critical care and cancer, announces that
the Company's Annual Report and Financial Statements for the year ended
31 March 2008, together with a Circular to Shareholders
containing the Notice of the Company's Annual General Meeting to be
held at 12.00 noon on Tuesday 22 July 2008 at the offices of Ashurst
LLP, Broadwalk House, 5 Appold Street, London EC2A 2HA, have been
posted to shareholders today.
